Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-30

Clinical Trial Update: Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating tiotropium for efficacy against allergen-induced early asthmatic responses in allergic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tiotropium (tiotropium)

Snippet

Sponsor: University of Saskatchewan | Conditions: Allergic Asthma | Phase 4 | Status: COMPLETED